NIH-funded research U01 cooperative agreement

Cure Glomerulonephropathy Network for Glomerular Disease Patients

Official title: The Columbia PCC for CureGN: the Cure Glomerulonephropathy network

Funded at Columbia University Health Sciences · NIH-11577754 · Data updated 2026-11-12

A national network studies kids and adults with common kidney diseases to understand how they progress and how treatments work.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 16, 2013
Project endMay 31, 2029
Funding year2026
Award (this year)$86,485
NIH project number3U01DK100876-14S1
Project IDNIH-11577754 on NIH RePORTER

Who could benefit from this research

Could help

Adults and children with Berger’s disease and related glomerular diseases who are enrolled in CureGN and followed longitudinally.

Less likely to help

Some participants may not experience direct treatment changes during the study period.

What this research studies

This project builds a large, long-term study of patients with glomerular diseases like MCD, FSGS, IgAN, and MN to collect clinical data, biospecimens, and patient-reported outcomes. It partners patients, clinicians, and researchers across many sites to share insights that could guide personalized care. The effort focuses on how diseases develop, how they respond to therapy, and what factors influence outcomes, with a strong emphasis on data sharing and translational research. Participants may contribute samples and information over time to help researchers uncover disease mechanisms and improve treatments.

Why it matters

Potential benefit: If successful, patients could benefit from better understanding of their disease course and more personalized treatment approaches.

How similar studies have gone: CureGN has enrolled nearly 2,800 participants, showing strong feasibility and rich data for glomerular disease research.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Bomback, Andrew Stephen — Columbia University Health Sciences
  • Study coordinator: Bomback, Andrew Stephen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.